T
BMY icon

Tidemark’s Bristol-Myers Squibb BMY Stock Holding History

Tidemark’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.4K Sell
1,152
-7,214
-86% -$414K 0.01% 271
2026
Q1 		$507K Buy
8,366
+56
+0.7% +$3.27K 0.13% 76
2025
Q4 		$448K Sell
8,310
-202
-2% -$9.72K 0.13% 77
2025
Q3 		$384K Buy
8,512
+7,214
+556% +$337K 0.11% 86
2025
Q2 		$60.1K Sell
1,298
-117
-8% -$5.74K 0.02% 218
2025
Q1 		$86.3K Sell
1,415
-648
-31% -$37.8K 0.03% 184
2024
Q4 		$117K Sell
2,063
-332
-14% -$18.6K 0.04% 159
2024
Q3 		$124K Buy
2,395
+12
+0.5% +$563 0.05% 145
2024
Q2 		$99K Buy
2,383
+843
+55% +$37.7K 0.05% 154
2024
Q1 		$83.5K Sell
1,540
-90
-6% -$4.58K 0.05% 185
2023
Q4 		$83.6K Buy
+1,630
New +$85.6K 0.05% 177

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tidemark's BMY Position: Q2 2026 in Review

Tidemark reduced its Bristol-Myers Squibb (BMY) stake by 86% in Q2 2026, selling an estimated $414K and leaving 1,152 shares worth $66.4K. The position accounts for 0.01% of the portfolio, ranked #271.

Tidemark first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $507K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tidemark held 1,152 shares of Bristol-Myers Squibb worth $66.4K as of Q2 2026.
  • Tidemark sold 7,214 Bristol-Myers Squibb shares in Q2 2026, an estimated $414K.
  • Bristol-Myers Squibb made up 0.01% of Tidemark's portfolio in Q2 2026, its #271 holding.
  • Tidemark first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Bristol-Myers Squibb position peaked at $507K in Q1 2026.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.